The final formal Planning Meeting took place in Beijing from 22-25 October 2006. At this meeting over 75 Abstracts were reviewed and podium and/or poster presentation sessions were assigned. Please note these assignments are tentative but changes will be relatively minor. Presenters will be notified of changes that effect them. Poster presentations will be listed within next two weeks; however, if presentation is not listed for Podium, please assume the presentation will be from Poster.
The Program:
(times, presentations and/or events may change)
Thursday December 7
1500-1830 Registration
1830-1900 Meeting of Session Chairs, Co-Chairs and Presenters
1900 - 2100 The Welcome Party
Friday December 8
0730-0830 Registration continues
0830-1000 The ICBPS Opening
• The State Food and Drug Administration (SFDA) Official Welcome and Address
• A Special Report, "New Emerging Issues with H5N1 Avian Flu in Indonesia"
Dr. Erna Tresnaningsih, Director Biomedical and Pharmacy R&D Center, Ministry of Health, Indonesia
• The international importance of furthering dialog, coordination/cooperation in critical areas such as biopharmaceuticals and pharmaceuticals.
David Poythress, The Adjutant General for the State of Georgia, US
1000-1020 Tea and Coffee Break
1020-1200 Session 1
• A Special CNBC - CD paper
• Partnerships: From Applied Science to Commercialization
Steven Bice, US
• Antibody-Based Biopharmaceuticals in China
Prof. Zhi-nan Chen, China
1200-1330 Lunch
1330-1510 Session 2
• A Special CNBC - LZ paper
• The Need for Innovation in the Development of New or Improved Vaccines
Luc Aujame, France
• Acambis Clinical Development of Programme for ChimeriVax-JE
Dr. Karen L. McCarthy
• CNBC Corporate
1510-1530 Tea and Coffee Break
1530-1700 Session 2 Continued
• Trend of the Third Revision of the Chinese Patent Law
Dr. Jia Chen, China
• An Overview of the Drug Sector within the Saudi Food and Drug Authority with Emphasis on Biologicals
Dr. Mohammed N. Al-Ahdal, Saudi Arabia
• Licensing of Medical Products Requires Using Alternate Approaches on Efficacy Demonstration when Traditional Human Clinical Trials are not Possible: US FDA Animal Rule and Biological Safety Considerations
Dr. James Estep, US
• The Clinical Trial for a New Drug
Dr. Wu Gang, Chin
Saturday December 9
0830-1000 Session 3
• A Novel Polyepitope Malaria Vaccine Randomly Constructed with Epitope Shuffling
Prof. Heng Wang, China
• The Adenovirus-Based Therapeutic Vaccine for Hepatitis B
Prof. Joe Zhou, China
• Non-replicating Adenovirus-Vectored Avian Influenza Vaccine
Dr. Kent Van Kampen, US
• A Study on the Process for the preparation of Proteosome Adjuvant of Vaccine and their Adjuvant Effect on Plague Vaccine Containing Recombinant F1-V Protein by Intranasally Immunization
Dr. Wu Xiu-fang, China
1000-1020 Break
1020-1210 Session 3 Continued
1020-1120
• Poster Session (3 minute oral for 20 selected posters)
1120-1210
• Poster Viewing
1210-1330 Lunch
1330-1510 Session 4
• Emerging Infections in the Asian Part of Russia
Prof. Sergey Netesov, Russia
• Alternate Treatment in Biological Crisis and Implications for the Pharmaceutical Industry
Dr. Florin Paul. Romania
• Key Factors in Growing European Biotechnology
Dr. Ben Prickril, France
• Corporate Overview: Emergent Biosolutions, US
1510-1530 Tea and Coffee Break
1530-1730 Session 4 Continued
• Anti-Microbial Drug Loaded Mucoadhesive Nanparticles for Opthalmic Delivery
Dharmendra Jain, India
• CD6-Targeted Immunotherapy: Back and Forward from Basic Research to the Clinical Setting
Dr. Enrique Montero, China
• The Mechanism, Safety and Efficacy of Gendicine®
Dr. Zhaohui Peng, China
• Correlation of Disulfide Bond Conformation to Hormonal Activity of Oxytocin
Prof. Anthony Tu, US
• CNBC Wuhan - special report
1830 Depart Hotel Crowne Plaza for Symposium Dinner
1900 Dinner at the Baijia Dayun - a very special venue
Sunday, December 10
0830-1000 Session 5
• Bridging the Gap Between Basic Research and Final Product Approval
Dr. Anna Johnson-Winegar, US
• Generics in Brazil: Lab Tested and Untested and a Comparison to Branded Drug
Dr. John Woodall, Brazil
• RNA Interference in Drug Target Identification and Validation
Dr. Chao Yueqiong, China
• The Many Faces of H5N1 - Applying an Understanding of Pathology and Pathogenesis towards the Development of Novel Biopharmaceuticals
Prof. Aileen Marty, US
1000-1020 Tea and Coffee Break
1020-1200 Session 5 Continued
• State-of-the-Art Platform for Rapid Biological Product Development
Dr. Liangzhi Xie, China
• Breakthrough Technology for Large-Scale Protein Production with Transient Transfection using CHO Suspension Cultures
Dr. Jack Zhai, US
• Traditional Knowledge and Indigenous Biotechnology in China
Dr. Susan Finston, US
• CNBC-SH - a special report
1200-1300 Lunch
1300 Buses leave for Great Wall tour. Please be on time.
Monday December 11
0830-1000 Session 6
• In Vitro and In Vivo Antimalarial Properties of Two Plants Used by Traditional Herbal Practitioners of Burkini Faso: Pavetta Crassipes and Mitragyna Inermis
Prof. Alfred S. Traore, Burkina Faso
• Bacteriophages - Alternate to Antibiotics Against Multi-Drug Resistant Bacterial Infections: From Former Soviet Experience to Worldwide Perspectives
Dr. Mzia Kutateladze, Republic of Georgia
• Use of Bacteriophage Lytic Enzymes for Effective Decontamination by Killing Antibiotic Resistant and other Pathogenic Bacteria
Dr. David Trudil, US
• Development and Optimization of a Recombinant Adenovirus Vectors Production Process
Dr. Zhao-Lie Chen, China
1000-1020 Tea and Coffee Break
1020-1200 Session 6 Continued
• CNBC-CC Special Report
• Summary from each Session Chair or Co-Chair
** 5 to 7 minutes for each Session
• A Farewell for all ICBPS members and their guests
1200-1300 Lunch
1300 Buses leave for Tour to Industry
____________________________________
Notes on the ICBPS venue - Crowne Plaza Hotel
1. The Hotel Crowne Plaza, Park View, Wuzhou, Beijing. This hotel on the 4th Ring road in north west quad is probably the closest and easiest to get to large name brand hotel from airport but cab drivers rarely speak other than Chinese. This is the Park View Wuzhou Crowne Plaza.
2. Crowne Plaza Park View is a large beautiful hotel with a great staff, excellent food and all amenities. The breakfast buffet is outstanding and much like those breakfasts at the Sheraton and Shangri La in previous SISPAT meetings. Lunches/dinners at any of the several hotel restaurants are nice and reasonably priced. Rooms are about 150%-200% larger than name brand hotel rooms in US/Europe at about 50% or less the cost in US/Europe.
3. The Crowne Plaza is at the heart of the Beijing Olympics (2008) and is a headquarters for the continuing IOC senior staff meetings. A couple blocks away is the now famous and very unique "Bird Cage" stadium - the central venue for the 2008 Olympics. A great experience to be in Beijing at the Crowne Plaza at this time.
4. We are still accepting new participants who have an interest in this vital area and we will continue to make, as long as possible, reservations at the Crowne Plaza at the nicely discounted rates as outlined in para K 2. in General Information.
|